Five-quarter earnings beat streak intact as Cardiovascular segment growth of 8.3% powers $0.86 EPS and $5.44 billion revenue, with FARAPULSE pulsed field ablation system delivering clinical momentum and management launching a $500 million cost-reduction push.
Boston Scientific :
BSX
BSX
Stock Data
$49.32
$0.02 (0.03%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Boston Scientific Corporation is a global leader in developing and manufacturing medical devices that cater to a wide range of interventional medical specialties. With a focus on improving patient outcomes, it offers innovative solutions for gastrointestinal, pulmonary, urological, neurological, and cardiovascular conditions. Its portfolio includes devices for diagnosing and treating coronary artery disease, heart rhythm disorders, and various forms of cancer. Founded in 1979 and based in Marlborough, Massachusetts, Boston Scientific is dedicated to transforming lives through medical innovation.
Latest Activity
All Boston Scientific Articles
262 Articles